BRPI0511931A - uso de 7-t-butoxiiminometilcamptotecina para a preparação de um medicamento para o tratamento de neoplasmas uterinos - Google Patents
uso de 7-t-butoxiiminometilcamptotecina para a preparação de um medicamento para o tratamento de neoplasmas uterinosInfo
- Publication number
- BRPI0511931A BRPI0511931A BRPI0511931-6A BRPI0511931A BRPI0511931A BR PI0511931 A BRPI0511931 A BR PI0511931A BR PI0511931 A BRPI0511931 A BR PI0511931A BR PI0511931 A BRPI0511931 A BR PI0511931A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- treatment
- medicament
- butoxyiminomethylcamptothecin
- uterine neoplasms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
USO DE 7-t-BUTOXIIMINOMETILCAMPTOTECINA PARA A PREPARAçãO DE UM MEDICAMENTO PARA O TRATAMENTO DE NEOPLASMAS UTERINOS. A presente invenção refere-se ao uso de 7-t-butoxiiminometil-cam-ptotecina que é descrito na preparação de um medicamento útil para o tratamento de neoplasmas uterinos, particularmente câncer do endométrio e do colo do útero.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000288A ITRM20040288A1 (it) | 2004-06-11 | 2004-06-11 | Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero. |
PCT/IT2005/000320 WO2005120643A2 (en) | 2004-06-11 | 2005-06-08 | Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0511931A true BRPI0511931A (pt) | 2008-01-22 |
Family
ID=34979678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0511931-6A BRPI0511931A (pt) | 2004-06-11 | 2005-06-08 | uso de 7-t-butoxiiminometilcamptotecina para a preparação de um medicamento para o tratamento de neoplasmas uterinos |
Country Status (23)
Country | Link |
---|---|
US (1) | US7700613B2 (pt) |
EP (1) | EP1773451B1 (pt) |
JP (2) | JP2008501785A (pt) |
KR (1) | KR101221640B1 (pt) |
CN (2) | CN104352496A (pt) |
AR (1) | AR049220A1 (pt) |
AT (1) | ATE521351T1 (pt) |
AU (1) | AU2005251573B2 (pt) |
BR (1) | BRPI0511931A (pt) |
CA (1) | CA2565213C (pt) |
CY (1) | CY1112032T1 (pt) |
DK (1) | DK1773451T3 (pt) |
ES (1) | ES2372056T3 (pt) |
HK (1) | HK1205951A1 (pt) |
HR (1) | HRP20110718T1 (pt) |
IT (1) | ITRM20040288A1 (pt) |
MX (1) | MXPA06014162A (pt) |
PL (1) | PL1773451T3 (pt) |
PT (1) | PT1773451E (pt) |
RS (1) | RS52038B (pt) |
SI (1) | SI1773451T1 (pt) |
TW (1) | TWI351283B (pt) |
WO (1) | WO2005120643A2 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008001970A (es) * | 2005-08-10 | 2008-03-24 | Novartis Ag | Formulaciones para 7-(t-butoxi)iminometil camptotecin. |
KR20090115856A (ko) * | 2007-02-01 | 2009-11-09 | 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. | 캄포테신 유도체를 함유하는 약학적 조성물 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0835258B1 (fr) * | 1995-06-21 | 2002-09-25 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant |
FR2757514B1 (fr) * | 1996-12-20 | 1999-02-12 | Sod Conseils Rech Applic | Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant |
UA57757C2 (uk) * | 1996-12-20 | 2003-07-15 | Сос'Єте Де Консей Де Решерш Е Даплікасьон С'Єнтіфік (С.К.Р.А.С.) | Аналоги камптотецину, спосіб їх отримання (варіанти) і фармацевтична композиція |
US7105492B2 (en) * | 1999-03-09 | 2006-09-12 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Camptothecin derivatives having antitumor activity |
ATE216998T1 (de) * | 1999-03-09 | 2002-05-15 | Sigma Tau Ind Farmaceuti | Camptothecin-derivate mit antitumor-wirkung |
IT1306129B1 (it) * | 1999-04-13 | 2001-05-30 | Sigma Tau Ind Farmaceuti | Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti |
US6352996B1 (en) * | 1999-08-03 | 2002-03-05 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
AU2002366100A1 (en) * | 2001-11-20 | 2003-06-10 | University Of Kentucky Research Foundation | Engineered liposomal particles containing core-loaded pro-drugs for the controlled release of camptothecins |
US20070123580A1 (en) * | 2003-05-21 | 2007-05-31 | Atadja Peter W | Combination of histone deacetylase inhibitors with chemotherapeutic agents |
-
2004
- 2004-06-11 IT IT000288A patent/ITRM20040288A1/it unknown
-
2005
- 2005-05-19 TW TW094116349A patent/TWI351283B/zh not_active IP Right Cessation
- 2005-06-08 MX MXPA06014162A patent/MXPA06014162A/es active IP Right Grant
- 2005-06-08 CN CN201410616189.7A patent/CN104352496A/zh active Pending
- 2005-06-08 EP EP05761294A patent/EP1773451B1/en active Active
- 2005-06-08 RS RS20110434A patent/RS52038B/en unknown
- 2005-06-08 PL PL05761294T patent/PL1773451T3/pl unknown
- 2005-06-08 KR KR1020067027912A patent/KR101221640B1/ko active IP Right Grant
- 2005-06-08 WO PCT/IT2005/000320 patent/WO2005120643A2/en active Application Filing
- 2005-06-08 PT PT05761294T patent/PT1773451E/pt unknown
- 2005-06-08 AT AT05761294T patent/ATE521351T1/de active
- 2005-06-08 ES ES05761294T patent/ES2372056T3/es active Active
- 2005-06-08 JP JP2007526712A patent/JP2008501785A/ja not_active Withdrawn
- 2005-06-08 CA CA2565213A patent/CA2565213C/en not_active Expired - Fee Related
- 2005-06-08 AU AU2005251573A patent/AU2005251573B2/en not_active Ceased
- 2005-06-08 CN CNA2005800157280A patent/CN1953784A/zh active Pending
- 2005-06-08 BR BRPI0511931-6A patent/BRPI0511931A/pt active Search and Examination
- 2005-06-08 DK DK05761294.7T patent/DK1773451T3/da active
- 2005-06-08 US US11/628,458 patent/US7700613B2/en not_active Expired - Fee Related
- 2005-06-08 SI SI200531393T patent/SI1773451T1/sl unknown
- 2005-06-13 AR ARP050102379A patent/AR049220A1/es unknown
-
2011
- 2011-10-05 HR HR20110718T patent/HRP20110718T1/hr unknown
- 2011-11-14 CY CY20111101092T patent/CY1112032T1/el unknown
-
2014
- 2014-08-15 JP JP2014165542A patent/JP2014231518A/ja active Pending
-
2015
- 2015-07-13 HK HK15106661.8A patent/HK1205951A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN104352496A (zh) | 2015-02-18 |
ES2372056T3 (es) | 2012-01-13 |
PT1773451E (pt) | 2011-11-02 |
TW200605891A (en) | 2006-02-16 |
TWI351283B (en) | 2011-11-01 |
WO2005120643A8 (en) | 2006-12-14 |
KR20070030246A (ko) | 2007-03-15 |
KR101221640B1 (ko) | 2013-01-14 |
CN1953784A (zh) | 2007-04-25 |
ATE521351T1 (de) | 2011-09-15 |
CA2565213A1 (en) | 2005-12-22 |
EP1773451B1 (en) | 2011-08-24 |
HK1205951A1 (en) | 2015-12-31 |
PL1773451T3 (pl) | 2012-01-31 |
US7700613B2 (en) | 2010-04-20 |
CA2565213C (en) | 2012-08-07 |
JP2014231518A (ja) | 2014-12-11 |
SI1773451T1 (sl) | 2012-01-31 |
JP2008501785A (ja) | 2008-01-24 |
HRP20110718T1 (hr) | 2011-12-31 |
AU2005251573A1 (en) | 2005-12-22 |
WO2005120643A2 (en) | 2005-12-22 |
AR049220A1 (es) | 2006-07-05 |
ITRM20040288A1 (it) | 2004-09-11 |
US20080020030A1 (en) | 2008-01-24 |
MXPA06014162A (es) | 2007-03-07 |
DK1773451T3 (da) | 2011-11-28 |
EP1773451A2 (en) | 2007-04-18 |
RS52038B (en) | 2012-04-30 |
WO2005120643A3 (en) | 2006-03-30 |
CY1112032T1 (el) | 2015-11-04 |
AU2005251573B2 (en) | 2010-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0618239A8 (pt) | uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos | |
BRPI0608815A8 (pt) | Composições de anticorpo anti-ctla-4 | |
GT200500137A (es) | Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis. | |
BRPI0507966A (pt) | uso de meloxicam para o tratamento de doenças respiratórias em porcos | |
CL2011002248A1 (es) | Composicion farmaceutica oral de liberacion inmediata que comprende oxicodona y naloxona en una proporcion 2:1 en peso; uso de la composicion farmaceutica para tratar dolor intercurrente en paciente que sufren de dolor. | |
BR112012009376A2 (pt) | composição farmacêutica, forma de dosagem farmacêutica, processo para a sua preparação, métodos de tratamento e seu uso | |
CL2010001365A1 (es) | Uso de fentermina en combinacion con topiramato para tratar la obesidad mediante una reduccion de peso en una persona. | |
CL2008000500A1 (es) | Combinacion farmaceutica que comprende una combinacion de dos o mas broncodilatadores o una combinacion de al menos un broncodilatador y al menos un corticosteroide; uso para tratar o prevenir una enfermedad respiratoria; e inhalador que comprende di | |
BRPI0603762A (pt) | uso de agomelatina para obtenção de medicamentos intencionados para o tratamento de distúrbios de sono em pacientes deprimidos | |
BRPI0814299B8 (pt) | preparação sólida compreendendo alogliptina e cloridreto de metformina, uso de uma preparação sólida, e, métodos para estabilizar um composto em uma preparação sólida, e para produzir uma preparação sólida | |
GT201200347A (es) | Derivados de 6,7-dihidro-5h-benzo[7]anulenos, métodos para su preparación, preparaciones farmacéuticas que los contienen y su uso para la preparación de medicamentos | |
AR062402A1 (es) | Uso de compuestos y derivados de 2,5-dihidroxibenceno para el tratamiento del cancer de piel | |
CL2007001724A1 (es) | Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1 | |
BRPI0706992C1 (pt) | composto de fórmula (i) e formulação farmacêutica | |
BRPI0511209A (pt) | composição farmacêutica e uso de uma associação de propionato de clobetasol e de calcitriol | |
HN2003000183A (es) | Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
DOP2014000124A (es) | Derivados de 6,7-dihidro-5h-benzo[7]anuleno, procesos para su preparación, productos farmacéuticos que comprenden a los mismos y su uso en la preparación de medicamentos | |
UY31990A (es) | Nuevos derivados | |
BRPI0518448A2 (pt) | composiÇÕes farmacÊuticas compreendendo um derivado de camptotecina | |
BR112022011445A2 (pt) | Composição imunoestimuladora e uso da mesma | |
BR112012022243A8 (pt) | Uso de um inibidor de autofagia baseado em tioxantona e de um composto indutor de autofagia para terapia de câncer, composição farmacêutica e kit farmacêutico | |
BRPI0511931A (pt) | uso de 7-t-butoxiiminometilcamptotecina para a preparação de um medicamento para o tratamento de neoplasmas uterinos | |
BRPI0415232A (pt) | uso de xenÈnio com hipotermia para tratar asfixia neonatal | |
BRPI0516545A (pt) | uso de óleo de lavanda para a profilaxia e tratamento de neurastenia, distúrbios de somatização e outras doenças associadas ao estresse | |
IS2488B (is) | Fyrirbygging á krabbameini í ristli og endaþarmi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/4741 (2006.01), A61P 35/00 (2006.01) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2437 DE 19/09/2017 POR TER SIDO INDEVIDA. |